CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-13 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $262.72 | $131K | 248,852 |
| 2026-07-13 | Sheena Jonathan Director | Sale 10b5-1 | −800 | $264.29 | $211K | 248,052 |
| 2026-07-13 | Sheena Jonathan Director | Sale 10b5-1 | −400 | $265.15 | $106K | 247,652 |
| 2026-07-13 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $266.75 | $133K | 247,152 |
| 2026-07-13 | Sheena Jonathan Director | Sale 10b5-1 | −450 | $267.72 | $120K | 246,702 |
| 2026-07-13 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $268.39 | $134K | 246,202 |
| 2026-07-06 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,000 | $280.00 | $280K | 4,000 |
| 2026-07-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −100 | $267.19 | $27K | 137,543 |
| 2026-07-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −2,600 | $272.99 | $710K | 134,943 |
| 2026-07-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −300 | $274.06 | $82K | 134,643 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,568 | $266.79 | $418K | 187,526 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −3,705 | $268.11 | $993K | 183,821 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,932 | $268.99 | $520K | 181,889 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −484 | $269.87 | $131K | 181,405 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,357 | $270.96 | $368K | 180,048 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −454 | $272.14 | $124K | 179,594 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −500 | $274.19 | $137K | 179,094 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,100 | $275.20 | $303K | 177,994 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,400 | $276.24 | $387K | 176,594 |
| 2026-07-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −2,045 | $277.29 | $567K | 174,549 |
Page 13 of 39 · 767 trades